Evidence map›Paper›PMID 29286450›Full record

ArticleJournal of visualized experiments : JoVE2017

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification.

Anthony A High, Haiyan Tan, Vishwajeeth R Pagala, Mingming Niu, Ji-Hoon Cho, Xusheng Wang, Bing Bai, Junmin Peng

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Characterization of a dual degrader of MDM2 and GSPT1.European journal of medicinal chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anthony A HighSt. Jude Proteomics Facility, St. Jude Children's Research Hospital; anthony.high@stjude.org.
Haiyan TanSt. Jude Proteomics Facility, St. Jude Children's Research Hospital.
Vishwajeeth R PagalaSt. Jude Proteomics Facility, St. Jude Children's Research Hospital.
Mingming NiuDepartments of Structural Biology and Developmental Neurobiology, St. Jude Children's Research Hospital; Heilongjiang University of Chinese Medicine.
Ji-Hoon ChoSt. Jude Proteomics Facility, St. Jude Children's Research Hospital.
Xusheng WangSt. Jude Proteomics Facility, St. Jude Children's Research Hospital.
Bing BaiDepartments of Structural Biology and Developmental Neurobiology, St. Jude Children's Research Hospital.
Junmin PengSt. Jude Proteomics Facility, St. Jude Children's Research Hospital; Departments of Structural Biology and Developmental Neurobiology, St. Jude Children's Research Hospital; junmin.peng@stjude.org.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Multi-level Integrative Proteomics to Alzheimer's Disease PathwaysR01AG053987 · NIA · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PENG, JUNMIN · 2016 to 2020
$2.2M
RNA splicing dysfunction in Alzheimer's diseaseR01AG047928 · NIA · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PENG, JUNMIN · 2015 to 2019
$1.8M
Proteomics Approaches to Protein TurnoverR01GM114260 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI PENG, JUNMIN · 2016 to 2019
$1.4M
NCI NIH HHS P30 CA021765NIA NIH HHS R01 AG047928NIA NIH HHS R01 AG053987NIGMS NIH HHS R01 GM114260
6 · The paper itself

Abstract

Many exceptional advances have been made in mass spectrometry (MS)-based proteomics, with particular technical progress in liquid chromatography (LC) coupled to tandem mass spectrometry (LC-MS/MS) and isobaric labeling multiplexing capacity. Here, we introduce a deep-proteomics profiling protocol that combines 10-plex tandem mass tag (TMT) labeling with an extensive LC/LC-MS/MS platform, and post-MS computational interference correction to accurately quantitate whole proteomes. This protocol includes the following main steps: protein extraction and digestion, TMT labeling, 2-dimensional (2D) LC, high-resolution mass spectrometry, and computational data processing. Quality control steps are included for troubleshooting and evaluating experimental variation. More than 10,000 proteins in mammalian samples can be confidently quantitated with this protocol. This protocol can also be applied to the quantitation of post translational modifications with minor changes. This multiplexed, robust method provides a powerful tool for proteomic analysis in a variety of complex samples, including cell culture, animal tissues, and human clinical specimens.

Indexed as

Chromatography, LiquidComputational BiologyGene Expression ProfilingHumansProteomicsSoftwareTandem Mass Spectrometry

Identifiers

PMID29286450
PMCPMC5755397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.